tiprankstipranks
Advertisement
Advertisement

VIR Stock Latest News

Vir Biotechnology Names Brent Sabatini Interim Finance Chief
Company AnnouncementsVir Biotechnology Names Brent Sabatini Interim Finance Chief
1d ago
8K
VIR
Vir Biotechnology CFO Jason O’Byrne to depart
PremiumThe Fly
Vir Biotechnology CFO Jason O’Byrne to depart
1d ago
VIR
Mirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley
1M ago
VIR
MIRM
Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley
PremiumThe Fly
Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley
1M ago
VIR
MIRM
Vir Biotechnology Adds Timothy Coughlin to Board, Audit Chair
PremiumCompany Announcements
Vir Biotechnology Adds Timothy Coughlin to Board, Audit Chair
1M ago
8K
VIR
Alec Stranahan Reiterates Buy on Vir Biotechnology, Sees Undervalued Pipeline with Unchanged $16 Price Target
PremiumRatingsAlec Stranahan Reiterates Buy on Vir Biotechnology, Sees Undervalued Pipeline with Unchanged $16 Price Target
2M ago
VIR
Vir Biotechnology Announces Board Changes and Shareholder Approvals
Premium
Company Announcements
Vir Biotechnology Announces Board Changes and Shareholder Approvals
2M ago
8K
VIR
Vir Biotechnology to present complete week 96 data from Phase 2 SOLSTICE trial
Premium
The Fly
Vir Biotechnology to present complete week 96 data from Phase 2 SOLSTICE trial
2M ago
VIR
Vir Biotechnology price target lowered to $23 from $24 at Morgan Stanley
PremiumThe Fly
Vir Biotechnology price target lowered to $23 from $24 at Morgan Stanley
3M ago
VIR
Analyst Maintains Buy Rating and $20 Price Target on Vir, Citing Strengthened Oncology Franchise and Favorable Hepatitis Delta Outlook
PremiumRatings
Analyst Maintains Buy Rating and $20 Price Target on Vir, Citing Strengthened Oncology Franchise and Favorable Hepatitis Delta Outlook
3M ago
VIR
Vir Biotechnology Signals Momentum in Latest Earnings Call
PremiumCompany Announcements
Vir Biotechnology Signals Momentum in Latest Earnings Call
3M ago
VIR
Vir Biotechnology Earns Buy Rating on Advancing Oncology and Hepatitis Delta Pipelines and Strong Cash Runway Into 2028
PremiumRatings
Vir Biotechnology Earns Buy Rating on Advancing Oncology and Hepatitis Delta Pipelines and Strong Cash Runway Into 2028
3M ago
VIR
Vir Biotechnology reports Q1 EPS (85c) vs. (88c) last year
PremiumThe FlyVir Biotechnology reports Q1 EPS (85c) vs. (88c) last year
3M ago
VIR
Analyst Reiterates Buy on Vir Biotechnology, Citing Best-in-Class HDV Profile and Maintaining $18 Price Target
Premium
Ratings
Analyst Reiterates Buy on Vir Biotechnology, Citing Best-in-Class HDV Profile and Maintaining $18 Price Target
3M ago
VIR
Vir Biotechnology Marks Key Hepatitis B Milestone With Phase 2 Combo Study Update
Premium
Company Announcements
Vir Biotechnology Marks Key Hepatitis B Milestone With Phase 2 Combo Study Update
3M ago
VIR
Vir Biotechnology closes global collaboration agreement with Astellas Pharma
PremiumThe Fly
Vir Biotechnology closes global collaboration agreement with Astellas Pharma
3M ago
SNY
VIR
Vir Biotechnology announces first patient dosed in Phase 1 trial of VIR-5500
PremiumThe Fly
Vir Biotechnology announces first patient dosed in Phase 1 trial of VIR-5500
3M ago
VIR
Vir Biotechnology Announces Upcoming Chief Medical Officer Transition
PremiumCompany Announcements
Vir Biotechnology Announces Upcoming Chief Medical Officer Transition
4M ago
8K
VIR
Vir Biotechnology Names CEO Marianne De Backer as President
PremiumCompany Announcements
Vir Biotechnology Names CEO Marianne De Backer as President
5M ago
8K
VIR
Vir Biotechnology price target raised to $20 from $15 at H.C. Wainwright
PremiumThe FlyVir Biotechnology price target raised to $20 from $15 at H.C. Wainwright
5M ago
VIR
Vir Biotechnology Raises Capital Through Public Stock Offering
Premium
Company Announcements
Vir Biotechnology Raises Capital Through Public Stock Offering
5M ago
8K
VIR
Vir Biotechnology Announces Significant Common Stock Offering
Premium
Company Announcements
Vir Biotechnology Announces Significant Common Stock Offering
5M ago
8K
VIR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >